| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/06/2014 | US8716267 Bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators |
| 05/06/2014 | US8716266 Use of PKC-iota inhibitors for the treatment of glioma |
| 05/06/2014 | US8716265 4-quinolinemethanols as anti-malarial agents |
| 05/06/2014 | US8716264 Compositions and methods for combination antiviral therapy |
| 05/06/2014 | US8716263 Synthesis of purine nucleosides |
| 05/06/2014 | US8716262 Nucleoside phosphoramidates |
| 05/06/2014 | US8716261 Maintenance of platelet inhibition during antiplatelet therapy |
| 05/06/2014 | US8716260 Use of S-adenosylmethionine, vitamin E, and vitamin C for the treatment of oxidative liver injury |
| 05/06/2014 | US8716259 Oligonucleotide chelate complexes |
| 05/06/2014 | US8716256 Method of therapy and diagnosis of atherosclerosis |
| 05/06/2014 | US8716255 Microrna compositions and methods for the treatment of myelogenous leukemia |
| 05/06/2014 | US8716253 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 05/06/2014 | US8716252 (Methylsulfonyl) ethyl benzene isoindoline derivatives and their pharmaceutical uses |
| 05/06/2014 | US8716251 Pharmaceutical formulations containing an SGLT2 inhibitor |
| 05/06/2014 | US8716250 Diazoxide for the treatment of Friedreich's ataxia |
| 05/06/2014 | US8716249 Compositions and methods for improving cardiovascular health |
| 05/06/2014 | US8716233 NOTCH mutations leading to increased receptor signaling |
| 05/06/2014 | US8716231 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| 05/06/2014 | US8716230 Methods for treatment or prevention of diseases associated with functional disorder of regulatory T cells |
| 05/06/2014 | US8716229 Osteoprotegerin in neuroprotection |
| 05/06/2014 | US8716180 Method of reducing mycotoxin contamination of the harvest |
| 05/06/2014 | US8715953 Analysis of sulfated polysaccharides |
| 05/06/2014 | US8715922 Virus causing respiratory tract illness in susceptible mammals |
| 05/06/2014 | US8715749 Products containing polyphenol(s) and L-arginine |
| 05/06/2014 | US8715735 Stabilised supersaturated solids of lipophilic drugs |
| 05/06/2014 | US8715734 Amoxicilline instant granulate |
| 05/06/2014 | US8715731 Process of reducing the bitter taste of water soluble actives by co-grinding the active with β cyclodextrin |
| 05/06/2014 | US8715728 Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |
| 05/06/2014 | US8715724 Tabletting process |
| 05/06/2014 | US8715721 Controlled release hydrocodone |
| 05/06/2014 | US8715719 Stable chitosan hemostatic implant and methods of manufacture |
| 05/06/2014 | US8715717 Composition for animal consumption |
| 05/06/2014 | US8715713 Solvent cast film sustained release latanoprost implant |
| 05/06/2014 | US8715710 Semi-solid delivery vehicle and pharmaceutical compositions for delivery of granisetron |
| 05/06/2014 | US8715709 Sustained release intraocular implants and methods for treating ocular neuropathies |
| 05/06/2014 | US8715708 Cyclic acetal biomaterials |
| 05/06/2014 | US8715706 Methods and devices for delivery of pharmaceutical agents within orifices of the body |
| 05/06/2014 | US8715701 Microstructural protein preparations containing adsorbed biologically active substances and their application in medicine and cosmetics |
| 05/06/2014 | US8715699 Amino acid conjugates of quetiapine, process for making and using the same |
| 05/06/2014 | US8715675 Vascular targets for detecting, imaging and treating neoplasia or neovasculature |
| 05/06/2014 | US8715668 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 and uses thereof |
| 05/06/2014 | US8715648 Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics |
| 05/06/2014 | US8715644 Method for decreasing borborygmi by administering a bifidobacterium bacteria |
| 05/06/2014 | US8715638 Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 05/06/2014 | US8715636 Polysaccharide-based polymer tissue adhesive for medical use |
| 05/06/2014 | US8715635 Frictionless molecular rotary motors |
| 05/06/2014 | US8715632 Compositions and methods for the protection of hair from treated pool water |
| 05/06/2014 | US8715627 Protection against sunburn and skin problems with topical and orally-ingested dosages of zeaxanthin |
| 05/06/2014 | US8715624 Stable liquid desoximethasone compositions with reduced oxidized impurity |
| 05/06/2014 | US8715623 Pulmonary delivery of aminoglycoside |
| 05/06/2014 | US8715529 Synthesis and applications of triazaborolopyridinium compounds and substituted triazaborolopyridinium compounds and methods of use |
| 05/06/2014 | US8715341 Drug-delivery endovascular stent and method of forming the same |
| 05/06/2014 | DE202013011160U1 Ölige Metronidazol-Suspension Oily metronidazole suspension |
| 05/06/2014 | DE202005022124U1 Antimikrobielle Lösungen aus Taurinamid-Derivaten und biologisch verträglichen Salzen und Säuren unter Zugabe von geringen Heparinkonzentrationen Antimicrobial solutions taurinamide derivatives and biologically acceptable salts and acids with the addition of low concentrations of heparin |
| 05/06/2014 | CA2798924C Improved methods for preparing squalene |
| 05/06/2014 | CA2793525C Method for improving dissolution of anticoagulant agent |
| 05/06/2014 | CA2768290C R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for thepreparation thereof and pharmaceutical composition comprising the same for antimicrobial |
| 05/06/2014 | CA2745774C Combination of lycopene, polyphenol, and vitamins for the care of keratin material |
| 05/06/2014 | CA2744985C Carboxylic acid derivative containing thiazole ring useful for the prevention or treatment of hyperlipidemia |
| 05/06/2014 | CA2744800C Method for selectively crystallizing a z isomer of iopromide |
| 05/06/2014 | CA2742539C Disubstituted phthalazine hedgehog pathway antagonists |
| 05/06/2014 | CA2729619C Nutritive compositions and methods of using same |
| 05/06/2014 | CA2718271C Azetidine and cyclobutane derivatives as jak inhibitors |
| 05/06/2014 | CA2696063C Immediate release and sustained release ibuprofen dosing form |
| 05/06/2014 | CA2666371C Use of an indazolemethoxyalkanoic acid to prepare a pharmaceutical composition |
| 05/06/2014 | CA2658379C Spirocyclic azaindole derivatives |
| 05/06/2014 | CA2655355C Use of rpn2 gene expression inhibitor |
| 05/06/2014 | CA2646899C Use of compositions containing kappa-opioid receptor antagonists for the treatment of dissociative disorders |
| 05/06/2014 | CA2634984C Use of tiotropium salts in the treatment of moderate persistent asthma |
| 05/06/2014 | CA2631816C Compounds with medicinal effects due to interaction with the glucocorticoid receptor |
| 05/06/2014 | CA2629311C Glucagon receptor antagonists, preparation and therapeutic uses |
| 05/06/2014 | CA2629172C Glucagon receptor antagonists, preparation and therapeutic uses |
| 05/06/2014 | CA2628305C Jelly composition |
| 05/06/2014 | CA2623294C 2-aminoethoxyacetic acid derivatives and their use |
| 05/06/2014 | CA2621899C Aryl/alkyl succinic anhydride hyaluronan derivatives |
| 05/06/2014 | CA2619834C Stabilized and preserved ketotifen ophthalmic compositions |
| 05/06/2014 | CA2618448C Fluorination process of anilide derivatives and benzothiazole fluorinate derivatives as in vivo imaging agents |
| 05/06/2014 | CA2617378C Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them |
| 05/06/2014 | CA2616768C 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents |
| 05/06/2014 | CA2610305C Formulations of lipoic acid and hyaluronic acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields |
| 05/06/2014 | CA2585638C Aminopyridine derivatives having aurora a selective inhibitory action |
| 05/06/2014 | CA2574040C Iap binding compounds |
| 05/06/2014 | CA2566340C Resistance-repellent retroviral protease inhibitors |
| 05/06/2014 | CA2527756C Immunostimulating agents |
| 05/06/2014 | CA2522294C Formulations and methods for treating rhinosinusitis |
| 05/06/2014 | CA2514474C Freeze-dried fibrin matrices and methods for preparation thereof |
| 05/06/2014 | CA2511838C Uses of mammalian cytokine; related reagents |
| 05/06/2014 | CA2508165C Pyridines for treating injured mammalian nerve tissue |
| 05/06/2014 | CA2475446C Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 05/06/2014 | CA2435982C Medicaments |
| 05/06/2014 | CA2307163C Process for stereoselective synthesis of prostacyclin derivatives |
| 05/02/2014 | DE202014101882U1 Orales Abgabesystem Oral delivery system |
| 05/01/2014 | WO2014066860A2 Methods of prognosticating and treating cancer |
| 05/01/2014 | WO2014066851A1 C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders |
| 05/01/2014 | WO2014066848A1 Super-enhancers and methods of use thereof |
| 05/01/2014 | WO2014066840A1 Aurora kinase inhibitors |
| 05/01/2014 | WO2014066836A1 Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome |
| 05/01/2014 | WO2014066834A1 Synergistic combination of immunologic inhibitors for the treatment of cancer |
| 05/01/2014 | WO2014066799A2 Modulators of resistant androgen receptor |
| 05/01/2014 | WO2014066797A1 Compositions comprising polyethylene glycol for use in the therapy of egfr-dependent cancers. |